CV Sciences, Inc. (OTCQB:CVSI) is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company’s hemp extracts and other proven, science-backed, natural ingredients and products are sold through a range of sales channels from B2B to B2C. The Company's PlusCBD™ branded products are sold at select retail locations throughout the U.S. and are the top-selling brands of hemp extracts in the natural products market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. With a commitment to science, PlusCBD™ product benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. PlusCBD™ was the first hemp extract supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. The Company’s plant-based food products are sold under the Cultured Foods brand. CV Sciences, Inc. has primary offices and facilities in San Diego, California, and Warsaw, Poland. The Company also operates a drug development program focused on developing and commercializing CBD-based novel therapeutics. Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.
Company profile
Ticker
CVSI
Exchange
Website
CEO
Joseph D. Dowling
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CannaVEST Corp., Foreclosure Solutions, Inc.
SEC CIK
Corporate docs
Subsidiaries
Star Sky Foods, LLC ...
IRS number
800944970
CVSI stock data
Latest filings (excl ownership)
DEF 14A
Definitive proxy
11 Apr 24
10-K
2023 FY
Annual report
29 Mar 24
8-K
CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
28 Mar 24
8-K
CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market
12 Dec 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
CV Sciences, Inc. Reports Third Quarter 2023 Financial Results
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results
14 Aug 23
8-K
Departure of Directors or Certain Officers
5 Jun 23
8-K
CV Sciences, Inc. Reports First Quarter 2023 Financial Results
15 May 23
Transcripts
CVSI
Earnings call transcript
2023 Q4
28 Mar 24
CVSI
Earnings call transcript
2023 Q3
14 Nov 23
CVSI
Earnings call transcript
2023 Q2
14 Aug 23
CVSI
Earnings call transcript
2023 Q1
15 May 23
CVSI
Earnings call transcript
2022 Q4
29 Mar 23
CVSI
Earnings call transcript
2022 Q3
14 Nov 22
CVSI
Earnings call transcript
2022 Q2
15 Aug 22
CVSI
Earnings call transcript
2022 Q1
16 May 22
CVSI
Earnings call transcript
2021 Q4
31 Mar 22
CVSI
Earnings call transcript
2021 Q3
15 Nov 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.64 mm | 1.64 mm | 1.64 mm | 1.64 mm | 1.64 mm | 1.64 mm |
Cash burn (monthly) | 15.67 k | (no burn) | 149.00 k | (no burn) | 6.33 k | (no burn) |
Cash used (since last report) | 112.41 k | n/a | 1.07 mm | n/a | 45.44 k | n/a |
Cash remaining | 1.53 mm | n/a | 573.95 k | n/a | 1.60 mm | n/a |
Runway (months of cash) | 97.7 | n/a | 3.9 | n/a | 252.2 | n/a |
Institutional ownership, Q4 2022
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 5.00 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Massmutual Trust Co FSB | 5.00 k | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Mar 23 | Grasser Joerg | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.04 | 1,250,000 | 50.00 k | 1,250,000 |
15 Mar 23 | Dowling Joseph D | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.04 | 2,500,000 | 100.00 k | 2,500,000 |
News
Cannabis Stock Gainers And Losers From May 3, 2024
3 May 24
Marijuana Stock Movers For May 1, 2024
1 May 24
Bullish Tuesday For Marijuana Stocks - Elixinol Wellness, Item 9 Labs Among Top Gainers
30 Apr 24
Bearish Sentiment Across The Cannabis Space - Check Full Movers For April 29, 2024
29 Apr 24
Cannabis Stock Gainers And Losers From April 26, 2024
26 Apr 24